Old drugs, new weapons: repurposing therapies against antimicrobial resistance
A comprehensive review maps how approved drugs—from anticancer agents to antidepressants—can be systematically repurposed to combat drug-resistant superbugs.
A comprehensive review maps how approved drugs—from anticancer agents to antidepressants—can be systematically repurposed to combat drug-resistant superbugs.
A new computational study maps the host genes dysregulated in MPOX and identifies five repurposable drug candidates supported by docking ...
A new preclinical study reports that atovaquone, an approved antiparasitic drug, was reformulated into lactoferrin-based nanomicelles that crossed into the ...
A new comparative docking study ranks the anthelmintic niclosamide and the plant alkaloid berberine against three key Helicobacter pylori enzymes, ...
For millions of people living with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, the search for answers has been a frustrating one. The ...
A combined bioinformatics and molecular simulation study identifies MMP1 as a shared hub gene and colchicine target linking gout and ...
Machine learning is accelerating target identification, toxicity prediction and drug repurposing, but researchers insist algorithmic discoveries still demand rigorous experimental ...
For decades, scientists have pursued a seductive idea in the fight against drug-resistant bacteria: instead of killing pathogens outright, simply ...
A comprehensive review finds that the lipid-lowering drug fenofibrate shows strong clinical evidence for slowing diabetic retinopathy and promising preclinical ...
Idiopathic pulmonary arterial hypertension (IPAH) has long puzzled physicians... The methodological architecture of the study deserves closer examination, because the ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine